News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
US Senate Panel Backs 12-Year Biotech Drug Shelter; Major Victory for Drug Makers Such as Amgen, Roche Holding AG
July 14, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Biotechnology medicines would be protected from cheaper rivals for 12 years under a plan that cleared a U.S. Senate committee on Monday.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Regulatory
Amgen
MORE ON THIS TOPIC
FDA
Replimune Soars Upon FDA Resubmission for Advanced Melanoma Drug
October 20, 2025
·
2 min read
·
Heather McKenzie
Approvals
Novo Secures Cardiovascular Expansion for Semaglutide Pill
October 20, 2025
·
2 min read
·
Tristan Manalac
Regulatory
FDA Hands Out First Commissioner’s Priority Vouchers to Regeneron, Sanofi, Disc, Others
October 17, 2025
·
2 min read
·
Tristan Manalac
Drug pricing
In Affordability Push, EMD Serono Joins TrumpRx While Roche Launches DTC Program
October 17, 2025
·
2 min read
·
Tristan Manalac
